Postoperative adjuvant chemotherapy for non-small cell lung cancer

Tatsuro Okamoto, Yukito Ichinose

Research output: Contribution to journalReview article

Abstract

Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.

Original languageEnglish
Pages (from-to)765-769
Number of pages5
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume32
Issue number6
Publication statusPublished - Jan 1 2005

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Postoperative adjuvant chemotherapy for non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this